{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:05:46Z","timestamp":1786997146164,"version":"build-2736575974"},"reference-count":72,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.steroids.2011.02.002","type":"journal-article","created":{"date-parts":[[2011,2,17]],"date-time":"2011-02-17T06:20:06Z","timestamp":1297923606000},"page":"531-539","source":"Crossref","is-referenced-by-count":67,"title":["Nomegestrol acetate, a novel progestogen for oral contraception"],"prefix":"10.1016","volume":"76","author":[{"given":"Alfred O.","family":"Mueck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regine","family":"Sitruk-Ware","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.steroids.2011.02.002_bib0005","unstructured":"United Nations DoEaSA, Population Division. World Contraceptive Use 2007. http:\/\/www.un.org\/esa\/population\/publications\/contraceptive2007\/contraceptive_2007_table.pdf; 2007 [accessed 05.08.09]."},{"key":"10.1016\/j.steroids.2011.02.002_bib0010","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/bmj.2.5703.203","article-title":"Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs","volume":"2","author":"Inman","year":"1970","journal-title":"Br Med J"},{"key":"10.1016\/j.steroids.2011.02.002_bib0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0378-5122(94)00856-3","article-title":"Oral contraceptive containing natural estradiol for premenopausal women","volume":"21","author":"Hirvonen","year":"1995","journal-title":"Maturitas"},{"key":"10.1016\/j.steroids.2011.02.002_bib0020","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0940-2993(98)80034-1","article-title":"Approaches to the replacement of ethinylestradiol by natural 17beta-estradiol in combined oral contraceptives","volume":"50","author":"Hoffmann","year":"1998","journal-title":"Exp Toxicol Pathol"},{"key":"10.1016\/j.steroids.2011.02.002_bib0025","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0015-0282(16)56210-4","article-title":"Ovulation inhibition with a combined oral contraceptive containing 1mg micronized 17 beta-estradiol","volume":"60","author":"Wenzl","year":"1993","journal-title":"Fertil Steril"},{"key":"10.1016\/j.steroids.2011.02.002_bib0030","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0010-7824(80)90010-4","article-title":"A randomized, double-blind study of two combined oral contraceptives containing the same progestogen, but different estrogens. World Health Organization Task Force on Oral Contraception","volume":"21","author":"Koetsawang","year":"1980","journal-title":"Contraception"},{"key":"10.1016\/j.steroids.2011.02.002_bib0035","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2165\/00002512-200421130-00004","article-title":"New progestogens: a review of their effects in perimenopausal and postmenopausal women","volume":"21","author":"Sitruk-Ware","year":"2004","journal-title":"Drugs Aging"},{"key":"10.1016\/j.steroids.2011.02.002_bib0040","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1471-0528.1987.tb02322.x","article-title":"Effect of nomegestrol acetate, a new 19-nor-progesterone derivative, on pituitary-ovarian function in women","volume":"94","author":"Bazin","year":"1987","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.steroids.2011.02.002_bib0045","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1210\/jc.84.11.4191","article-title":"The antigonadotropic activity of a 19-nor-progesterone derivative is exerted both at the hypothalamic and pituitary levels in women","volume":"84","author":"Couzinet","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2011.02.002_bib0050","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S1297-9589(02)00009-7","article-title":"Antigonadotropic effects of a 19-nor-progesterone derivative: the example of nomegestrol acetate","volume":"31","author":"Jamin","year":"2003","journal-title":"Gynecol Obstet Fertil"},{"issue":"Suppl. 1","key":"10.1016\/j.steroids.2011.02.002_bib0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/13697130500148875","article-title":"Pharmacology of estrogens and progestogens: influence of different routes of administration","volume":"8","author":"Kuhl","year":"2005","journal-title":"Climacteric"},{"key":"10.1016\/j.steroids.2011.02.002_bib0060","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0015-0282(16)58204-1","article-title":"Effects of a single contraceptive silastic implant containing nomegestrol acetate on ovarian function and cervical mucus production during 2 years","volume":"65","author":"Barbosa","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.steroids.2011.02.002_bib0065","series-title":"The 8th Congress of the European Society of Gynecology","article-title":"Synergistic effect of 17 \u03b2-estradiol and nomegestrol acetate used in a new monophasic oral contraceptive","author":"Chabbert-Buffet","year":"2009"},{"key":"10.1016\/j.steroids.2011.02.002_bib0070","series-title":"XIX FIGO World Congress of Gynecology and Obstetrics","article-title":"Comparison of two regimens of new monophasic oral contraceptive combining 17 beta-estradiol and nomegestrol acetate","author":"Serfaty","year":"2009"},{"key":"10.1016\/j.steroids.2011.02.002_bib0075","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2165\/11532130-000000000-00000","article-title":"Nomegestrol acetate: pharmacology, safety profile and therapeutic efficacy","volume":"70","author":"Lello","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.steroids.2011.02.002_bib0080","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/humupd\/dmi046","article-title":"New progestagens for contraceptive use","volume":"12","author":"Sitruk-Ware","year":"2006","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.steroids.2011.02.002_bib0085","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.maturitas.2004.01.001","article-title":"Pharmacological profile of progestins","volume":"47","author":"Sitruk-Ware","year":"2004","journal-title":"Maturitas"},{"issue":"Suppl. 3","key":"10.1016\/j.steroids.2011.02.002_bib0090","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/13697130500330382","article-title":"Pharmacology of different progestogens: the special case of drospirenone","volume":"8","author":"Sitruk-Ware","year":"2005","journal-title":"Climacteric"},{"key":"10.1016\/j.steroids.2011.02.002_bib0095","first-page":"710","article-title":"The pharmacological profile of TX 066 (17 alpha-acetoxy-6-methyl-19-nor-4,6-pregna-diene-3,20-dione), a new oral progestative","volume":"33","author":"Paris","year":"1983","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.steroids.2011.02.002_bib0100","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0039-128X(91)90055-Z","article-title":"Interaction of [3H]nomegestrol acetate with cytosolic progesterone receptors from the rat uterus","volume":"56","author":"Duc","year":"1991","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2011.02.002_bib0105","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1530\/acta.0.1150544","article-title":"The cellular mechanism of the antiandrogenic action of nomegestrol acetate, a new 19-nor progestagen, on the rat prostate","volume":"115","author":"Botella","year":"1987","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.steroids.2011.02.002_bib0110","first-page":"70","article-title":"Antiandrogenic properties of nomegestrol acetate","volume":"45","author":"Duc","year":"1995","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.steroids.2011.02.002_bib0115","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0960-0760(95)00171-U","article-title":"Nomegestrol acetate, a clinically useful 19-norprogesterone derivative which lacks estrogenic activity","volume":"55","author":"Catherino","year":"1995","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.steroids.2011.02.002_bib0120","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S0022-3565(25)23767-3","article-title":"Regulation of rat uterine steroid receptors by nomegestrol acetate, a new 19-nor-progesterone derivative","volume":"248","author":"Botella","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.steroids.2011.02.002_bib0125","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0022-3565(25)39233-5","article-title":"Extinction of mineralocorticoid effects in 19-norprogesterone derivatives: structure-activity relationships","volume":"243","author":"Paris","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.steroids.2011.02.002_bib0130","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0960-0760(93)90105-6","article-title":"Enzyme immunoassay for nomegestrol acetate in human plasma","volume":"46","author":"Ezan","year":"1993","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.steroids.2011.02.002_bib0135","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0010-7824(91)90126-Z","article-title":"Effect of nomegestrol acetate on spinability, ferning and mesh dimension of midcycle cervical mucus","volume":"43","author":"Chretien","year":"1991","journal-title":"Contraception"},{"key":"10.1016\/j.steroids.2011.02.002_bib0140","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.contraception.2006.07.013","article-title":"Effects of a single Silastic contraceptive implant containing nomegestrol acetate (Uniplant) on endometrial morphology and ovarian function for 1 year","volume":"74","author":"Barbosa","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.steroids.2011.02.002_bib0145","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0010-7824(93)90112-K","article-title":"One year contraception with a single subdermal implant containing nomegestrol acetate (Uniplant)","volume":"47","author":"Coutinho","year":"1993","journal-title":"Contraception"},{"key":"10.1016\/j.steroids.2011.02.002_bib0150","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/humrep\/12.4.708","article-title":"Hormonal profile, endometrial histology and ovarian ultrasound assessment during 1 year of nomegestrol acetate implant (Uniplant)","volume":"12","author":"Devoto","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1016\/j.steroids.2011.02.002_bib0155","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2165\/00003495-200060040-00003","article-title":"Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms","volume":"60","author":"Godsland","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.steroids.2011.02.002_bib0160","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(94)90286-0","article-title":"Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation","volume":"344","author":"Vandenbroucke","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.steroids.2011.02.002_bib0165","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.contraception.2006.12.019","article-title":"The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation","volume":"75","author":"Dinger","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.steroids.2011.02.002_bib0170","first-page":"482","article-title":"Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?","volume":"81","author":"Odlind","year":"2002","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.steroids.2011.02.002_bib0175","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0010-7824(91)90080-Y","article-title":"Effects of nomegestrol acetate (5mg\/d) on hormonal, metabolic and hemostatic parameters in premenopausal women","volume":"44","author":"Basdevant","year":"1991","journal-title":"Contraception"},{"key":"10.1016\/j.steroids.2011.02.002_bib0180","first-page":"441","article-title":"Effects of nomegestrol acetate on carbohydrate metabolism","volume":"19","author":"Dorangeon","year":"1993","journal-title":"Diabete Metab"},{"key":"10.1016\/j.steroids.2011.02.002_bib0185","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1096\/fj.06-6840com","article-title":"Progestins overcome inhibition of platelet aggregation by endothelial cells by down-regulating endothelial NO synthase via glucocorticoid receptors","volume":"21","author":"Zerr-Fouineau","year":"2007","journal-title":"Faseb J"},{"key":"10.1016\/j.steroids.2011.02.002_bib0190","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1161\/ATVBAHA.108.178004","article-title":"Certain progestins prevent the enhancing effect of 17beta-estradiol on NO-mediated inhibition of platelet aggregation by endothelial cells","volume":"29","author":"Zerr-Fouineau","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"Suppl. 13","key":"10.1016\/j.steroids.2011.02.002_bib0195","first-page":"53","article-title":"Hormone replacement therapy and coronary artery atherosclerosis: the monkey model","volume":"103","author":"Clarkson","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.steroids.2011.02.002_bib0200","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1161\/01.CIR.81.5.1680","article-title":"Estrogen modulates responses of atherosclerotic coronary arteries","volume":"81","author":"Williams","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.steroids.2011.02.002_bib0205","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/0735-1097(94)90184-8","article-title":"Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys","volume":"24","author":"Williams","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.steroids.2011.02.002_bib0210","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0002-9378(98)70149-8","article-title":"Coadministration of nomegestrol acetate does not diminish the beneficial effects of estradiol on coronary artery dilator responses in nonhuman primates (Macaca fascicularis)","volume":"179","author":"Williams","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.steroids.2011.02.002_bib0215","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0039-128X(00)00118-5","article-title":"Nomegestrol acetate and vascular reactivity: nonhuman primate experiments","volume":"65","author":"Paris","year":"2000","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2011.02.002_bib0220","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0960-0760(98)00020-X","article-title":"Estrogens, progestins, and coronary artery reactivity in atherosclerotic monkeys","volume":"65","author":"Williams","year":"1998","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.steroids.2011.02.002_bib0225","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(96)90806-5","article-title":"Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies","volume":"347","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.steroids.2011.02.002_bib0230","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.4065\/81.10.1290","article-title":"Oral contraceptive use as a risk factor for premenopausal breast cancer: a meta-analysis","volume":"81","author":"Kahlenborn","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.steroids.2011.02.002_bib0235","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMoa013202","article-title":"Oral contraceptives and the risk of breast cancer","volume":"346","author":"Marchbanks","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.steroids.2011.02.002_bib0240","doi-asserted-by":"crossref","first-page":"c927","DOI":"10.1136\/bmj.c927","article-title":"Mortality among contraceptive pill users: cohort evidence from Royal College of General Practitioners\u2019 Oral Contraception Study","volume":"340","author":"Hannaford","year":"2010","journal-title":"Br Med J"},{"key":"10.1016\/j.steroids.2011.02.002_bib0245","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1677\/erc.0.0100179","article-title":"Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells","volume":"10","author":"Doisneau-Sixou","year":"2003","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.steroids.2011.02.002_bib0250","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/oxfordjournals.jncimonographs.a024237","article-title":"Estrogen receptor-mediated processes in normal and cancer cells","author":"Dickson","year":"2000","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.steroids.2011.02.002_bib0255","first-page":"575","article-title":"A prospective study of estradiol and breast cancer in Japanese women","volume":"9","author":"Kabuto","year":"2000","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.steroids.2011.02.002_bib0260","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/oxfordjournals.aje.a117278","article-title":"Premenopausal estradiol levels and the risk of breast cancer: a new method of controlling for day of the menstrual cycle","volume":"140","author":"Rosenberg","year":"1994","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.steroids.2011.02.002_bib0265","first-page":"79","article-title":"A prospective study of endogenous hormones and breast cancer","volume":"18","author":"Helzlsouer","year":"1994","journal-title":"Cancer Detect Prev"},{"key":"10.1016\/j.steroids.2011.02.002_bib0270","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/bjc.1997.183","article-title":"A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey","volume":"75","author":"Thomas","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1016\/j.steroids.2011.02.002_bib0275","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/oxfordjournals.aje.a114596","article-title":"Sex hormone levels in serum in relation to the development of breast cancer","volume":"125","author":"Wysowski","year":"1987","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.steroids.2011.02.002_bib0280","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/jnci\/dji132","article-title":"Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC)","volume":"97","author":"Kaaks","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.steroids.2011.02.002_bib0285","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jsbmb.2003.08.003","article-title":"An overview of nomegestrol acetate selective receptor binding and lack of estrogenic action on hormone-dependent cancer cells","volume":"87","author":"Shields-Botella","year":"2003","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.steroids.2011.02.002_bib0290","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1210\/en.142.9.3791","article-title":"A-ring reduced metabolites of 19-nor synthetic progestins as subtype selective agonists for ER alpha","volume":"142","author":"Larrea","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2011.02.002_bib0295","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0014-2999(01)00893-7","article-title":"In vitro metabolism of gestodene in target organs: formation of A-ring reduced derivatives with oestrogenic activity","volume":"417","author":"Lemus","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.steroids.2011.02.002_bib0300","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0960-0760(00)00125-4","article-title":"Hormonal properties of norethisterone, 7alpha-methyl-norethisterone and their derivatives","volume":"74","author":"Schoonen","year":"2000","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.steroids.2011.02.002_bib0305","first-page":"2827","article-title":"Control of sulfatase activity by nomegestrol acetate in normal and cancerous human breast tissues","volume":"25","author":"Chetrite","year":"2005","journal-title":"Anticancer Res"},{"key":"10.1016\/j.steroids.2011.02.002_bib0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsbmb.2004.11.004","article-title":"Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells","volume":"93","author":"Shields-Botella","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.steroids.2011.02.002_bib0315","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/bjc.1993.175","article-title":"Norgestrel and gestodene stimulate breast cancer cell growth through an oestrogen receptor mediated mechanism","volume":"67","author":"Catherino","year":"1993","journal-title":"Br J Cancer"},{"key":"10.1016\/j.steroids.2011.02.002_bib0320","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0960-0760(94)90170-8","article-title":"Inhibition by nomegestrol acetate and other synthetic progestins on proliferation and progesterone receptor content of T47-D human breast cancer cells","volume":"50","author":"Botella","year":"1994","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.steroids.2011.02.002_bib0325","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1210\/me.15.12.2093","article-title":"Stromal PRs mediate induction of 17beta-hydroxysteroid dehydrogenase type 2 expression in human endometrial epithelium: a paracrine mechanism for inactivation of E2","volume":"15","author":"Yang","year":"2001","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.steroids.2011.02.002_bib0330","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1210\/jcem-52-2-252","article-title":"Influence of endometrial 17 beta-hydroxysteroid dehydrogenase activity on the binding of estradiol to receptors","volume":"52","author":"Gurpide","year":"1981","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2011.02.002_bib0335","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0378-5122(89)90117-5","article-title":"The effects of the addition of nomegestrol acetate to post-menopausal oestrogen therapy","volume":"11","author":"Fraser","year":"1989","journal-title":"Maturitas"},{"key":"10.1016\/j.steroids.2011.02.002_bib0340","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1471-0528.1997.tb11458.x","article-title":"Impact of percutaneous oestradiol gels in postmenopausal hormone replacement therapy on clinical symptoms and endometrium","volume":"104","author":"Foidart","year":"1997","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.steroids.2011.02.002_bib0345","doi-asserted-by":"crossref","unstructured":"Duijkers I, Klipping, C, Grob, P, Korver, T. Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17\u03b2-oestradiol on ovarian function in comparison to a monophasic combined oral contraceptive containing drospirenone and ethinylestradiol. Eur J Contracept Reprod Health Care 2010;15:314-25.","DOI":"10.3109\/13625187.2010.504313"},{"key":"10.1016\/j.steroids.2011.02.002_bib0350","series-title":"Effects of an oral contraceptive containing nomegestrol acetate and 17beta-estradiol on carbohydrate metabolism","author":"\u00c5gren","year":"2010"},{"key":"10.1016\/j.steroids.2011.02.002_bib0355","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0960-0760(96)00094-5","article-title":"Effect of nomegestrol acetate on estrone-sulfatase and 17beta-hydroxysteroid dehydrogenase activities in human breast cancer cells","volume":"58","author":"Chetrite","year":"1996","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.steroids.2011.02.002_bib0360","first-page":"4651","article-title":"Effect of nomegestrol acetate on human estrogen sulfotransferase activity in the hormone-dependent MCF-7 and T-47D breast cancer cell lines","volume":"23","author":"Chetrite","year":"2003","journal-title":"Anticancer Res"}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X11000420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X11000420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T13:35:46Z","timestamp":1740922546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X11000420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":72,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0039128X11000420"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2011.02.002","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}